8 July, 2016 by The TZ Newswire Staff Comments Off on A Value Investor’s Checklist
A Value Investor’s Checklist
In this clip from Industry Focus: Tech, Motley Fool analyst John Rotonti shares a few of the most important metrics he uses to measure the investment potential of companies that have piqued his interest.
A transcript follows the video.
{%sfr%}{%video%}
8 July, 2016 by The TZ Newswire Staff Comments Off on A quick crunch of the US and Canadian jobs numbers due
A quick crunch of the US and Canadian jobs numbers due
Here’s what’s expected today
US jobs
Canada jobs
The market will want to see the headline NFP return to some sort of normality, then focus will swing to wages. As always look at participation rate to see if it’s had a big influence on the unemployment rate.
8 July, 2016 by The TZ Newswire Staff Comments Off on Currencies: Dollar edges lower as investors await June jobs number
Currencies: Dollar edges lower as investors await June jobs number
The dollar edged lower against the yen and a host of other rivals Friday as investors awaited the release of the June jobs report.
read more
8 July, 2016 by The TZ Newswire Staff Comments Off on Early movers: GPS, MCD, JUNO, VLKAY, HUM, AET, INTC & more
Early movers: GPS, MCD, JUNO, VLKAY, HUM, AET, INTC & more
Names on the move ahead of the open.
8 July, 2016 by The TZ Newswire Staff Comments Off on One Trader’s Take On Today’s Jobs Number
One Trader’s Take On Today’s Jobs Number
From Bloomberg’s Richard Breslow
Non-farm payrolls are coming. There’s no shortage of opinions on what the numbers will be. And if they come in as widely expected, they’ll be pretty good. Good enough that had this been last month, we’d still be having the tiresome “every month is live” debate.
This time around, markets may have to deal with how to trade a result where the number is sound, maybe even outright strong, and we’re still on perma-hold.
8 July, 2016 by The TZ Newswire Staff Comments Off on Why Biogen Inc. Stock Dropped 15.7% in June
Why Biogen Inc. Stock Dropped 15.7% in June
Image source: Getty Images.
What: Shares of Biogen Inc. (NASDAQ: BIIB), a large neurology-focused biotechnology company, tumbled 15.7% last month, according to data from S&P Global Market Intelligence. Disappointing clinical results from a long shot new drug candidate was the main culprit.